The Partial REBOA Outcomes Multicenter Prospective Trial (PROMPT) was selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly $6 million in funding from the U.S. Department of Defense grant awarded through the Medical Technology Enterprise Consortium (MTEC).